Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

Nature communications·2026
Same author

Plasma Citrate Levels Are Inversely Associated with Estimated Muscle Mass and Strength in Liver Transplant Recipients.

International journal of molecular sciences·2026
Same author

High-Density Lipoprotein-Specific Phospholipid Efflux (HDL-SPE) Assay in Mice.

Molecular nutrition & food research·2026
Same author

In Reply to Inter-Instrument Imprecision Complements Bias in Evaluating LDL-C Method Performance.

Clinical chemistry·2026
Same author

Corrigendum to "Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights" [J Clin Lipidol (2026) S1933-2874(26)00045-0, ahead of print].

Journal of clinical lipidology·2026
Same author

Permanent Lipid Lowering with CRISPR-Based Interventions: Redefining Laboratory Medicine in the Era of Gene Editing.

Clinical chemistry·2026
Same journal

RETRACTED: Atta et al. Effect of Montmorillonite Nanogel Composite Fillers on the Protection Performance of Epoxy Coatings on Steel Pipelines. <i>Molecules</i> 2017, <i>22</i>, 905.

Molecules (Basel, Switzerland)·2026
Same journal

Correction: Chen et al. Chemical Composition of <i>Litsea pungens</i> Essential Oil and Its Potential Antioxidant and Antimicrobial Activities. <i>Molecules</i> 2023, <i>28</i>, 6835.

Molecules (Basel, Switzerland)·2026
Same journal

Correction: Ruan et al. Comparison of Extraction, Isolation, Purification, Structural Characterization and Immunomodulatory Activity of Polysaccharides from Two Species of <i>Cistanche</i>. <i>Molecules</i> 2025, <i>30</i>, 4754.

Molecules (Basel, Switzerland)·2026
Same journal

Correction: Li et al. Gastrodin Ameliorates Cognitive Dysfunction in Vascular Dementia Rats by Suppressing Ferroptosis via the Regulation of the Nrf2/Keap1-GPx4 Signaling Pathway. <i>Molecules</i> 2022, <i>27</i>, 6311.

Molecules (Basel, Switzerland)·2026
Same journal

Correction: Zueva et al. Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry. <i>Molecules</i> 2020, <i>25</i>, 1371.

Molecules (Basel, Switzerland)·2026
Same journal

1,4-Diazatriphenylene and Its Hetero-Fused Analogs: Synthesis and Applications.

Molecules (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2025

Shotgun Lipidomics of Rodent Tissues
11:46

Shotgun Lipidomics of Rodent Tissues

Published on: November 18, 2022

2.0K

A High-Throughput NMR Method for Lipoprotein-X Quantification.

Erwin Garcia1, Irina Shalaurova1, Steven P Matyus1

  • 1Labcorp, Morrisville, NC 27560, USA.

Molecules (Basel, Switzerland)
|February 10, 2024
PubMed
Summary
This summary is machine-generated.

A new proton nuclear magnetic resonance (NMR) spectroscopy assay detects abnormal Lipoprotein X (LP-X) particles. This method aids in diagnosing cholestatic liver disease and familial lecithin-cholesterol acyltransferase deficiency (FLD).

Keywords:
LCAT deficiencycholestasishypercholesterolemialipoprotein-X

More Related Videos

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
11:13

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

8.8K
Enrichment of Bacterial Lipoproteins and Preparation of N-terminal Lipopeptides for Structural Determination by Mass Spectrometry
10:59

Enrichment of Bacterial Lipoproteins and Preparation of N-terminal Lipopeptides for Structural Determination by Mass Spectrometry

Published on: May 21, 2018

8.7K

Related Experiment Videos

Last Updated: Jul 3, 2025

Shotgun Lipidomics of Rodent Tissues
11:46

Shotgun Lipidomics of Rodent Tissues

Published on: November 18, 2022

2.0K
Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
11:13

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

8.8K
Enrichment of Bacterial Lipoproteins and Preparation of N-terminal Lipopeptides for Structural Determination by Mass Spectrometry
10:59

Enrichment of Bacterial Lipoproteins and Preparation of N-terminal Lipopeptides for Structural Determination by Mass Spectrometry

Published on: May 21, 2018

8.7K

Area of Science:

  • Biochemistry
  • Clinical Chemistry
  • Medical Diagnostics

Background:

  • Lipoprotein X (LP-X) is an abnormal, cholesterol-rich lipoprotein.
  • LP-X accumulates in patients with cholestatic liver disease and familial lecithin-cholesterol acyltransferase deficiency (FLD).
  • Current diagnostic methods for LP-X lack high-throughput capabilities.

Purpose of the Study:

  • To develop and validate a proton nuclear magnetic resonance (NMR) spectroscopy-based assay for LP-X detection.
  • To implement the assay on a clinical NMR analyzer for routine laboratory testing.

Main Methods:

  • Proton nuclear magnetic resonance (NMR) spectroscopy was used to quantify LP-X.
  • Assay linearity, functional sensitivity, and precision (intra- and inter-assay CV) were evaluated.
  • Interference from bilirubin and hemolysis, and sample stability were assessed.

Main Results:

  • The LP-X assay demonstrated linearity from 89 to 1615 mg/dL with a functional sensitivity of 44 mg/dL.
  • Intra-assay CV ranged from 1.8–11.8%, and inter-assay CV ranged from 1.5–15.4%.
  • The assay showed no significant interference from bilirubin or hemolysis and samples were stable for 6 days at 4°C.

Conclusions:

  • A novel, robust NMR-based assay for LP-X has been developed.
  • This assay is suitable for routine clinical laboratory implementation.
  • The assay can aid in the diagnosis of liver conditions associated with LP-X accumulation.